Table 3.
Classification and representative structures of advanced glycation end-products
|
AGE type
|
Chemical name
|
Characteristics
|
Biological activity
|
| CML | CML | One of the most common AGEs; formed via glycoxidation or lipid peroxidation | RAGE agonist; promotes inflammation and fibrosis |
| CEL | CEL | Structurally similar to CML; derived from pyruvate and other metabolic intermediates | Associated with insulin resistance |
| Pentosidine | Crosslink product of reducing sugars with lysine or arginine | Signature structure of AGE crosslinks | Strongly associated with bone fragility and arterial stiffness |
| MG-H1 | MG-H1 | Key biomarker of diabetes-related AGE | Promotes apoptosis and mitochondrial dysfunction |
CML: Nepsilon-(carboxymethyl)lysine; CEL: Nepsilon-(carboxyethyl)lysine; MG-H1: Methylglyoxal-derived hydroimidazolone 1; AGE: Advanced glycation end product; RAGE: Receptor for advanced glycation end products.